InvestorLens

CNMD — CONMED CORP

Health Care

Sign in to save5 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying CNMD?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence
95
Institutional Conviction
Net accumulation · 4 buying vs 0 selling last quarter
74
Macro Tailwind
Macro conditions are a headwind for Health Care
44
Why? — Evidence & Confidence ▾

Of 4 tracked investors who changed their CNMD position last quarter, 4 bought and 0 sold (100% buy-side). Macro conditions are a headwind for Health Care (Macro Tailwind 44/100 in a Overheat regime).

Supporting evidence
  • +4 tracked investors added or increased positions last quarter (Izzy Englander, Steve Cohen, Paul Tudor Jones, …)
  • +5 tracked investors reported holding CNMD at their latest filing
Contradicting evidence — always shown
  • −Current Overheat regime has historically been a headwind for Health Care (Macro Tailwind 44/100)
  • −13F data is disclosed up to 45 days after quarter end — positions may have changed since
Know the limits
  • · 13F disclosure lag (up to 45 days)
  • · Tracked investors are a sample, not the whole market
  • · Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 10/21/2026.

About CONMED CORP (CNMD)

CONMED CORP (CNMD) appears in the most recent 13F filings of 5 tracked institutional investors. CONMED CORP is classified in the Health Care sector. The largest disclosed position is held by Steve Cohen (Point72 Asset Management), valued at $67M. Across recent filings, tracked investors recorded 10 new positions, 6 increased, 4 reduced, and 5 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in CNMD

64
/100
Institutional Accumulation
Added / Increased16
Reduced4
Exited5
BearishBullish
Crowded Trade Score™

How many top investors track CNMD

33
/100
Emerging Interest
5investors

A small number of top investors own this.

UndiscoveredCrowded
151015+

CNMD Ownership Composition

How CONMED CORP is held across tracked investor types, based on reported 13F positions.

Dominant Type
Value & Distressed
82% of tracked value
Institutions
5
tracked investors
Total Reported
$64.1M
combined 13F value
Types3
  • Value & Distressed81.8%
  • Multi-Strategy / Quant17.0%
  • Macro1.2%
Value & Distressed(1)
81.8%
Multi-Strategy / Quant(3)
17.0%
Macro(1)
1.2%

Tracked investors currently reporting CNMD

1 tracked investor has since exited this position — listed separately below.

  • Steve CohenJun 30, 2026
    Point72 Asset Management
    Shares
    69.6K
    Value
    $2.3M
    % Portfolio
    0.00%
  • Howard MarksJun 30, 2026
    Oaktree Capital Management
    Shares
    53.6M
    Value
    $52.5M
    % Portfolio
    0.73%
  • Izzy EnglanderJun 30, 2026
    Millennium Management
    Shares
    114.6K
    Value
    $3.8M
    % Portfolio
    0.00%
  • Ken GriffinJun 30, 2026
    Citadel Advisors
    Shares
    148.6K
    Value
    $4.9M
    % Portfolio
    0.00%
  • Paul Tudor JonesJun 30, 2026
    Tudor Investment Corp
    Shares
    23.3K
    Value
    $762.7K
    % Portfolio
    0.00%

Previously held CNMD

These investors reported CNMD in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.

InvestorFirmLast reported sharesValue thenLast held
Ray DalioBridgewater Associates5.9K$279KSep 30, 2025

Recent activity

Frequently asked questions

How many institutional investors hold CNMD?
5 tracked institutional investors disclosed a position in CNMD (CONMED CORP) in their most recent 13F filing.
Who is the largest institutional holder of CNMD?
Steve Cohen, Point72 Asset Management, holds the largest disclosed position in CNMD, valued at $67M.
Did institutional ownership of CNMD increase or decrease?
Across recent 13F filings, tracked investors recorded 10 new positions, 6 increased, 4 reduced, and 5 fully exited CNMD.
What sector is CNMD in?
CONMED CORP is classified in the Health Care GICS sector.
Where does this CNMD ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.